covid treatment – Albanian  Telegraphic  Agency. https://en.ata.gov.al News Agency Mon, 28 Jun 2021 18:14:28 +0000 en-US hourly 1 New promising studies / Brataj: Tofacitinib lowers death incidence in patients with COVID-19 pneumonia https://en.ata.gov.al/2021/06/28/new-promising-studies-brataj-tofacitinib-lowers-death-incidence-in-patients-with-covid-19-pneumonia/ https://en.ata.gov.al/2021/06/28/new-promising-studies-brataj-tofacitinib-lowers-death-incidence-in-patients-with-covid-19-pneumonia/#respond Mon, 28 Jun 2021 18:09:51 +0000 http://en.ata.gov.al/?p=153728 TIRANA, June 28 /ATA/ – The Director General of the National Medical Emergency Centre Skënder Brataj said Monday that recent studies offer hopeful results in the treatment of COVID-19 patients.

Brataj said that Pfizer’s Tofacitinib lowers the incidence of death or respiratory failure in hospitalized patients with COVID-19 pneumonia. According to him, trial demonstrates cumulative incidence of death or respiratory failure through day 28 was much lower with tofacitinib compared with placebo, in hospitalized patients with COVID-19.

“Tofacitinib inhibits the production of interleukin-17 and gamma interferon, which are implicated in the pathogenesis of acute respiratory distress syndrome, a common complication of COVID-19 infection. Therefore, tofacitinib has the potential to act in more than one way to treat people infected with COVID-19,” Braraj said.

The trial was a research collaboration between Pfizer and the ARO from the Hospital Israelita Albert Einstein in Sao Paulo, Brazil, which was the trial coordinating center.

/j.p/u.sh/

]]> https://en.ata.gov.al/2021/06/28/new-promising-studies-brataj-tofacitinib-lowers-death-incidence-in-patients-with-covid-19-pneumonia/feed/ 0